David A. Stevens, Thomas C. Merigan
Citation Information: J Clin Invest. 1972;51(5):1170-1178. https://doi.org/10.1172/JCI106910.
David A. Stevens, Thomas C. Merigan
Published May 1, 1972
Citation Information: J Clin Invest. 1972;51(5):1170-1178. https://doi.org/10.1172/JCI106910.
Abstract
The influence of several factors on the course of herpes zoster was studied in 151 patients. Dissemination of zoster was associated with the presence of a concurrent disease, especially Hodgkin's disease, and/or the use of immunosuppressive therapy. Several host-immune parameters, including quantitative immunoglobulins, circulating lymphocyte counts, delayed hypersensitivity to multiple skin test antigens, and lymphocyte transformation to phytohemagglutinin did not correlate with dissemination of disease. Development of virus-specific complement-fixing antibody (CFA) was delayed in some patients with disseminated disease.
Authors
David A. Stevens, Thomas C. Merigan
Full Text PDF
Download PDF (1.36 MB)
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)